Exhibit 2.1
                                                                     -----------

                             STATEMENT OF CONTROL PERSON


The Statement on this Schedule 13G/A dated February 14, 2003 with respect to the
common stock par value $0.001 per share of Incyte Genomics Inc. is filed by
Samuel D. Isaly in accordance with the provisions of Rule 13d-1(b) and Rule
13d-1(k), respectively, as a control person (HC) of OrbiMed Advisors LLC,
OrbiMed Advisors Inc. and OrbiMed Capital LLC.

OrbiMed Advisors Inc. and OrbiMed Advisors LLC file this statement on Schedule
13G/A in accordance with the provisions of Rule 13d-1(b) and Rule 13d-1(k),
respectively, as an investment advisor (IA) and OrbiMed Capital LLC files this
statement on Schedule 13G/A in accordance with the provisions of Rule 13d-1(c)
and Rule 13d-1(k), respectively, as a corporation (CO).